[go: up one dir, main page]

ES2054668T3 - Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica. - Google Patents

Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica.

Info

Publication number
ES2054668T3
ES2054668T3 ES87304427T ES87304427T ES2054668T3 ES 2054668 T3 ES2054668 T3 ES 2054668T3 ES 87304427 T ES87304427 T ES 87304427T ES 87304427 T ES87304427 T ES 87304427T ES 2054668 T3 ES2054668 T3 ES 2054668T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
carcinomas
diseases
treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87304427T
Other languages
English (en)
Inventor
Juan Carlos Vidal
Luis Alberto Costa
Plata Guillermo Jose Hernandez
Molina Carlos Maria Coni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventech Research Inc
Original Assignee
Ventech Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventech Research Inc filed Critical Ventech Research Inc
Application granted granted Critical
Publication of ES2054668T3 publication Critical patent/ES2054668T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPLEJO DE CROTOXINA SUBGRUPOS A Y B OBTENIBLE MEDIANTE SEPARACION CROMATOGRAFICA A PARTIR DE VENENO EN BRUTO DE CROTALUS DURSSUS TERRIFICUS, ES UTIL PARA EL TRATAMIENTO DE CARCINOMAS Y TRASTORNOS VASCULARES, INFECCIOSOS O ENDOCRINOS, TALES COMO DIABETES, Y PARA EL TRATAMIENTO DEL DOLOR EN GENERAL.
ES87304427T 1986-05-19 1987-05-19 Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica. Expired - Lifetime ES2054668T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AR30400686 1986-05-19
AR30419586 1986-06-02

Publications (1)

Publication Number Publication Date
ES2054668T3 true ES2054668T3 (es) 1994-08-16

Family

ID=25590979

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87304427T Expired - Lifetime ES2054668T3 (es) 1986-05-19 1987-05-19 Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica.

Country Status (4)

Country Link
EP (1) EP0246861B1 (es)
JP (1) JPH0720875B2 (es)
DE (1) DE3784768T2 (es)
ES (1) ES2054668T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1019068E (pt) 1996-09-11 2009-10-08 Elizabeth Shanahan-Prendergast Formulações terapêuticas contendo veneno de serpente e/ou insecto para a profilaxia e terapia de neoplasmas
SG129211A1 (en) * 1997-11-06 2007-02-26 Univ Singapore Therapeutic molecules
JP2003504339A (ja) * 1999-07-14 2003-02-04 エス・アイ・エス・シユロブ・インステイテユート・フオー・サイエンス・リミテツド へび毒からの鎮痛剤
EP1391207A1 (en) * 2001-04-24 2004-02-25 Luis Alberto Costa Use of a phospholipase a2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids
DE10322656A1 (de) * 2003-05-20 2004-12-09 Toximed Gmbh Pharmazeutischer Wirkstoff
WO2005107357A2 (en) * 2004-05-06 2005-11-17 Laboratório Biosintética Ltda. Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE675605C (de) * 1936-09-11 1939-06-02 August Wolff Sudbracker Naehrm Verfahren zur Trennung und Gewinnung der wertvollen Bestandteile des Bienen- und Schlangengiftes
US4341762A (en) * 1981-04-07 1982-07-27 Haast William E Use of snake venoms for treatment of neurological and related disorders

Also Published As

Publication number Publication date
EP0246861A2 (en) 1987-11-25
JPS6333334A (ja) 1988-02-13
EP0246861B1 (en) 1993-03-17
DE3784768D1 (de) 1993-04-22
EP0246861A3 (en) 1989-01-04
DE3784768T2 (de) 1993-06-24
JPH0720875B2 (ja) 1995-03-08

Similar Documents

Publication Publication Date Title
DE69333348T2 (de) Anti-idiotypischer Antikörper und seine Verwendung zur Diagnose und Therapie bei HIV-bezogenen Krankheiten
Magalhães et al. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
IE38602L (en) Aryloxyalkanolamine derivatives
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2196849T3 (es) 4-amino-2-aril-pirimidinas sustituidas, su preparacion, su utilizacion y preparados farmaceuticos que las contienen.
ES2067250T5 (es) Preparado farmaceutico sin disolventes para administracion oral, con liberacion retardada de la sustancia activa y procedimiento para su fabricacion.
ES2054668T3 (es) Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica.
ATE205401T1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
CY1108648T1 (el) Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας
Burce et al. Immunological interactions between Trichinella spiralis and Trichuris muris in the intestine of the mouse
NO873273D0 (no) Flergranultablett for avgivelse av en aktiv bestanddel over tid.
ES2061495T3 (es) Peptidos relacionados con el virus htlv-iii, anticuerpos para los peptidos, vacunas, inmunizacion activa y pasiva contra el virus del sida y prueba diagnostica para la deteccion serologica del virus del sida.
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
NO985571L (no) Legemiddel for autoimmunsykdommer
Schwyzer et al. Neue Synthesen auf dem Gebiete der melanophorenstimulierenden und corticotropen Hormone
EP1050309A4 (en) NEUROTROPHIC FACTOR SECRETION PROMOTERS
Bianchetti et al. Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat
Jhaveri et al. Relationship of blood pressure to blood lead concentrations in small children
Dreizen et al. The effect of ACTH and cortisone on the sodium and potassium levels of human saliva
Versteeg et al. Inhibition of centrally-evoked pressor responses by neurohypophyseal peptides and their fragments
Strong et al. Conservative treatment of Morton's neuroma
ATE131729T1 (de) 3,5-diiod-l-thyronin zur tsh-suppression und behandlung von struma
Perlman A study of the therapeutic action and toxicity of pentaerythritol tetranitrate
Zaidat et al. Neuromuscular transmission defect caused by carbamazepine1

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 246861

Country of ref document: ES